Champlain Investment Partners, LLC Pulmonx Corp Transaction History

Champlain Investment Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$4.92 - $17.35 $497,953 - $1.76 Million	-101,210 Reduced 3.61%	2,701,250 $22.8 Million
Q3 2022 Nov 14, 2022	BUY	$15.35 - $23.99 $10.3 Million - $16.1 Million	672,700 Added 31.59%	2,802,460 $46.7 Million
Q2 2022 Aug 12, 2022	SELL	$14.0 - $27.95 $836,570 - $1.67 Million	-59,755 Reduced 2.73%	2,129,760 $31.4 Million
Q1 2022 May 12, 2022	BUY	$21.13 - $35.65 $2.16 Million - $3.65 Million	102,370 Added 4.9%	2,189,515 $54.3 Million
Q4 2021 Feb 10, 2022	BUY	$29.72 - $45.1 $8.49 Million - $12.9 Million	285,580 Added 15.85%	2,087,145 $66.9 Million
Q3 2021 Nov 12, 2021	BUY	$35.98 - $44.48 $26.5 Million - $32.8 Million	736,550 Added 69.16%	1,801,565 $64.8 Million
Q2 2021 Aug 12, 2021	BUY	$37.61 - $48.0 $22.3 Million - $28.4 Million	592,270 Added 125.28%	1,065,015 $47 Million
Q1 2021 May 13, 2021	BUY	$44.0 - $67.54 $20.8 Million - $31.9 Million	472,745 New	472,745 $21.6 Million

116

30.6M

400

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $309M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Champlain Investment Partners, LLC with notifications on news.